News

From "fast-follow" to "first-in-class/best-in-class", Chinese R&D teams have repeatedly set new records in global clinical ...
Chinese mid-cap stocks will be the next winners as companies take advantage of advancements in artificial intelligence, ...
It takes courage to speak up in China, but not only have murmurs arisen, many are warning of what could go wrong if AI is ...
A clinical trial led by London Health Sciences Centre Research Institute (LHSCRI) and Western University's Schulich School of ...
FROM artificial intelligence to military defence, China has offered a few DeepSeek moments this year, showing that the ...
The portfolio continues to invest in companies we believe are strong and improving and have improvement that is sustainable.
Each of these approaches can be explained another way as harnessing the capabilities of an existing AI model to assist in the ...
Meta Platforms Inc. is close to finalizing an investment of over $10 billion in Scale AI. According to people who know the ...
While some hail DeepSeek as a formidable competitor, others view it as a natural second-mover gaining advantage in an ...
Learn how Deepseek AI is transforming science by uncovering hidden insights in data, driving breakthroughs in medicine & ...
Armed with funding, algorithms, and a tip line, this new effort aims to dig corrupt studies out of medical literature before ...
DeepSeek's latest R1 model update brings enhanced performance at a low cost. The tech industry doesn't really care this time.